Relmada Therapeutics Inc.

0.73
0.04 (5.80%)
At close: Apr 24, 2025, 3:19 PM

Relmada Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Jun 30, 2019 Jun 30, 2018 Jun 30, 2017
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a 1.26K 3.75K n/a 4.87K 2.63K 85.27K
n/a n/a n/a -1.26K -3.75K n/a -4.87K -2.63K -85.27K
n/a -103.7M -161.25M -125.7M -60.84M -15.11M -12.73M -6.92M -7.22M
n/a n/a 2.66M 1.2M 1.4M 104.11 -761.04K n/a n/a
n/a -98.79M -157.04M -125.75M -59.46M -15.01M -17.32M -8.96M -6.29M
n/a -98.79M -157.04M -125.75M -59.46M -15.01M -17.32M -8.96M -6.29M
24.25M 48.89M 47.93M 35.08M 24.87M 7.25M 5.7M 3.97M 5.93M
5.93M 54.81M 113.32M 90.62M 35.97M 7.86M 7.02M 2.94M 1.29M
n/a -293 6.35M n/a n/a n/a n/a 2.35K 216.21K
30.18M 103.7M 161.25M 125.7M 60.84M 15.11M 12.73M 6.92M 7.22M
n/a n/a n/a n/a n/a n/a n/a 1.34M 550.00
n/a n/a n/a n/a n/a n/a n/a n/a n/a
n/a 103.7M 161.25M 125.7M 60.84M 15.11M 12.73M 6.92M 7.22M
n/a n/a -2.66M 48.32K -1.38M -1 4.59M 2.05M -716.1K
30.17M 30.1M 29.63M 17.55M 15.59M 9.23M 6.31M 3.14M 3.02M
30.17M 30.1M 29.63M 17.55M 15.59M 9.23M 6.31M 3.14M 3.02M
n/a -3.28 -5.3 -7.16 -3.81 -1.63 -2.74 -2.86 -2.08
n/a -3.28 -5.3 -7.16 -3.81 -1.63 -2.74 -2.86 -2.08
n/a 4.91M -157.04M -125.75M -59.45M -15.1M -16.55M -6.91M -6.92M
n/a -98.79M -157.04M -125.75M -59.46M -15.11M -16.56M -6.92M -7.01M
n/a 103.7M 2K 1.26K 3.75K 4.36K 4.87K 2.63K 85.27K